EpCAM is expressed in approximately 35% of HCC cases.19 Furthermore, tumor cells that have undergone epithelial-to-mesenchymal transition (EMT) often show reduced EpCAM expression, potentially leading to the oversight of EMT-type CTCs. This evidence concerns the gene EPCAM and hepatocellular carcinoma.